Evaluation of the therapeutic effect of edoxaban in VTE patients

Evaluation of the therapeutic effect of edoxaban in VTE patients - Evaluation of the therapeutic effect of edoxaban in VTE patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018515

Enrollment

Registered

2015-08-01

Start date

2015-07-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thromboembolism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who participated in medical examination and treatment using edoxaban in our hospital

Exclusion criteria

Exclusion criteria: The person bleeding at present

Design outcomes

Primary

Measure	Time frame
regression of the thombus after 3 months of treatment are evaluated using ultrasonography or CT	—

Secondary

Measure	Time frame
Anemia and influence to the kidney function before and after therapy are evaluated by blood test	—

Countries

Japan

Contacts

Public ContactKazuhiro Shimizu

Toho University Sakura Medical Center Internal medicinae cardiology division

k432@sakura.med.toho-u.ac.jp+81-43-462-8811

Outcome results